Recent Updates
Recently added Catalysts
ENOV Positive Sentiment Score: 70/100

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

Key Takeaway: Enovis Corporation will host a conference call on May 8, 2025, to discuss its first quarter financial results. The call is scheduled for 8:30 a.m. Eastern Time, with an earnings press release to be issued earlier that morning. Investors can access the live webcast and participate via phone using the provided information. Enovis emphasizes its commitment to innovation and improving patient outcomes through its range of medical technology products.

Market Sentiment Analysis

POSITIVE FACTORS

  • Enovis is showcasing transparency by hosting a conference call to discuss financial results.
  • The company's focus on innovation and improvement can lead to positive patient outcomes.
  • Investors are given multiple means of accessing important financial information.

Full Press Release Details

Wilimington, DE, April 17, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2025 financial results on Thursday, May 8th, 2025 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, can be accessed from the "Investors" section of Enovis' website at www.enovis.com.
Conference Call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 335-0887 and use the Access Code: 482081. Participants may also preregister at this link. A replay of the call will also be available on the Enovis website later that day.
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Vice President, Investor Relations

Frequently Asked Questions

When will Enovis announce its Q1 2025 financial results?

Enovis will announce its Q1 2025 financial results on May 8th, 2025.

How can I access Enovis' investor conference call?

You can access the call by dialing (833) 335-0887 and using Access Code: 482081.

Is a replay of the investor call available?

Yes, a replay of the call will be available on the Enovis website later that day.

What stock exchange is Enovis listed on?

Enovis is listed on the New York Stock Exchange under the symbol ENOV.

Where can I find more information about Enovis?

More information about Enovis can be found at www.enovis.com.

Last updated: Apr 17, 2025